(Q84876020)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21886174%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

title

SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21886174%20AND%20SRC:MED&resulttype=core&format=json

Refractory anemia with ring sideroblasts

12 February 2020

main subject

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21886174%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Jaroslaw P. Maciejewski

object named as

J P Maciejewski

0 references

author name string

V Visconte

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21886174%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

H Makishima

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21886174%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

A Jankowska

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21886174%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

H Szpurka

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21886174%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

A Jerez

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21886174%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

C O'Keefe

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21886174%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

H J Rogers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21886174%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

M A Sekeres

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21886174%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

R V Tiu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21886174%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

2 September 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21886174%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21886174%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21886174%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21886174%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

542-545

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21886174%20AND%20SRC:MED&resulttype=core&format=json

Ring sideroblasts and sideroblastic anemias

12 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.232

7 January 2021

Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.232

7 January 2021

Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.232

7 January 2021

Refractory anemia with ringed sideroblasts associated with marked thrombocytosis harbors JAK2 mutation and shows overlapping myeloproliferative and myelodysplastic features

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.232

7 January 2021

The JAK2-V617F mutation and essential thrombocythemia features in a subset of patients with refractory anemia with ring sideroblasts (RARS)

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.232

7 January 2021

High occurrence of JAK2 V617 mutation in refractory anemia with ringed sideroblasts associated with marked thrombocytosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.232

7 January 2021

High frequency of the JAK2 V617F mutation in patients with thrombocytosis (platelet count>600x109/L) and ringed sideroblasts more than 15% considered as MDS/MPD, unclassifiable

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.232

7 January 2021

DNMT3A Mutations in Acute Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.232

7 January 2021

Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AML.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.232

7 January 2021

JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.232

7 January 2021

Recurrent DNMT3A mutations in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.232

7 January 2021

Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.232

7 January 2021

Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.232

7 January 2021